The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study-Reference-Cited by-同舟云学术

The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study

Published:2009-02 Issue:2 Volume:67 Page:228-233
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Gjerden Pål,Bramness Jørgen G.,Slørdal Lars

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2008.03342.x/fullpdf

Reference26 articles.

1. Skeletal muscle relaxant use in the United States: data from the Third National Health and Nutrition Examination Survey (NHANES 3);Dillon;Spine,2004

2. Clinical and pharmacological review of the efficacy of orphenadrine and its combinations with paracetamol in painful conditions;Hunskaar;J Int Med Res,1991

3. Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: a placebo-controlled study using laser-induced somatosensory-evoked potentials from capsaicin-induced hyperalgesic human skin;Schaffler;Drugs R&D,2005

4. Misuse of anticholinergic drugs by people with serious mental illness;Buhrich;Psychiatr Serv,2000

5. Anticholinergic drugs used in Parkinson's disease: an overlooked class of drugs from a pharmacokinetic perspective;Brocks;J Pharm Pharmaceut Sci,1999

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous diclofenac and orphenadrine for the treatment of postoperative pain after remifentanil-based anesthesia;Wiener klinische Wochenschrift;2022-12-28

2. Does the Anticholinergic Drug Biperiden Affect Early Neural Tube Development in Chick Embryos?;Mustafa Kemal Üniversitesi Tıp Dergisi;2022-06-18

3. Treatment initiation for parkinson’s disease in Australia 2013–2018: a nation-wide study;BMC Geriatrics;2022-06-03

4. Misuse of Anticholinergic Medications: A Systematic Review;Biomedicines;2022-02-01

5. Assessment of gabapentin misuse using prescription drug monitoring program data;Substance Abuse;2021-03-09